The latest research results support Harvard's discovery that Novo Nordisk diet drug Ozempic is related to rare visual loss, and the large-scale test results show that Novo Nordisk diet drug Ozempic is related to rare visual loss, which supports the research results given by Harvard University earlier this year. Obese patients who use Ozempic are more than twice as likely to be diagnosed with NAION. NAION occurs when the blood flow decreases and damages the optic nerve. The risk of eye conditions is still low; Patients should pay attention. Novo Nordisk Denmark's share price once fell more than 3.3%.New york cocoa futures rose more than 4% to $11,296 a tonne.Brazilian President Lula posted a video on social media for the first time after undergoing head surgery.
The pharmacy chain WBA rose to 4%. It is reported that Sycamore Partners LP is arranging a debt financing plan for the acquisition of WBA. Sycamore has contacted lenders such as Bank of America and JPMorgan Chase.According to sources, the US Securities and Exchange Commission has extended the time limit for elon musk to respond to the Twitter investigation and settlement proposal until Monday.Fitch: Adjust the outlook of Uzbekistan to negative.
Zambian President Cillema met with Shao Hong, and Zambian President Cillema met with Shao Hong, Vice Chairman of the National Committee of CPPCC in Lusaka on the 12th.Google spokesperson: Google intends to appeal the decision of the Turkish Competition Authority.Francois bayrou, the new French Prime Minister: Reducing French debt is a moral obligation.